MS
Same song, slightly higher note
Morgan Stanley just gave Morgan Stanley a modest glow-up: the firm kept its Overweight rating on MS and lifted its price target to $223 from $219. Not exactly a moonshot, but it’s still a signal that the bull camp thinks the stock has more room to run.
Why you should care
Analyst calls don’t move mountains on their own, but they can nudge sentiment—especially when the target gets ratcheted higher instead of cut. For MS investors, the message is basically: “we still like the story,” even if the valuation is looking a little frothy.
The catch in the fine print
The stock page also flags a few less cheerful bits:
- The current price is sitting well above GF Value, which screams “rich” in a very polite way.
- GF Score is still strong at 81/100, so the business isn’t exactly limping.
- Insider selling has totaled $25.2 million over the last three months, which can make you raise an eyebrow and clutch your coffee a little tighter.
Big picture: this is a gentle bullish tweak, not a victory lap. The Street still likes MS, but it’s clearly asking for a better price before getting too excited.